Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

CI-958 for treatment of prostate cancer

Sep. 20, 1996

Further approval recommended for Novantrone

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Mitsui Toatsu claims long-acting oral form of MS-551

Sep. 13, 1996

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...